UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 597

Sortiert nach

Therapeutic Hypothermia After Cardiac Arrest

Circulation (New York, N.Y.), 2013-01, Vol.127 (2), p.244-250

SCIRICA, Benjamin M

2013

Volltextzugriff (PDF)

Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association

Circulation (New York, N.Y.), 2020-12, Vol.142 (24), p.e454-e468

2020

Volltextzugriff (PDF)

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

Circulation (New York, N.Y.), 2019-03, Vol.139 (11), p.1384-1395

2019

Volltextzugriff (PDF)

Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association

Circulation (New York, N.Y.), 2020-03, Vol.141 (10), p.e615-e644

2020

Volltextzugriff (PDF)

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Circulation (New York, N.Y.), 2014-10, Vol.130 (18), p.1579-1588

2014

Volltextzugriff (PDF)

In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine

Circulation (New York, N.Y.), 2021-08, Vol.144 (6), p.487-498

2021

Volltextzugriff (PDF)

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery

Circulation (New York, N.Y.), 2019-01, Vol.139 (4), p.489-501

2019

Volltextzugriff (PDF)

Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis–Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)

Circulation (New York, N.Y.), 2016-03, Vol.133 (10), p.997-1005

2016

Volltextzugriff (PDF)

Pulling Out All the Stops: A Case of Progressive Dyspnea

Circulation (New York, N.Y.), 2023-02, Vol.147 (8), p.688-693

2023

Volltextzugriff (PDF)

Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2°P-TIMI 50

Circulation (New York, N.Y.), 2013-04, Vol.127 (14), p.1522-1529

2013

Volltextzugriff (PDF)

"The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension

Circulation (New York, N.Y.), 2022-05, Vol.145 (22), p.1629-1631

2022

Volltextzugriff (PDF)

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus

Circulation (New York, N.Y.), 2019-11, Vol.140 (19), p.1569-1577

2019

Volltextzugriff (PDF)

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Circulation (New York, N.Y.), 2016-07, Vol.134 (4), p.304-313

2016

Volltextzugriff (PDF)

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial

Circulation (New York, N.Y.), 2019-09, Vol.140 (12), p.1004-1014

2019

Volltextzugriff (PDF)

Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus

Circulation (New York, N.Y.), 2013-03, Vol.127 (9), p.965-967

Scirica, Benjamin M

2013

Volltextzugriff (PDF)

Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Circulation (New York, N.Y.), 2014-12, Vol.130 (25), p.2295-2301

2014

Volltextzugriff (PDF)

Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control

Circulation (New York, N.Y.), 2021-02, Vol.143 (5), p.507-509

2021

Volltextzugriff (PDF)

Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF

Circulation (New York, N.Y.), 2022-09, Vol.146 (11), p.808-818

2022

Volltextzugriff (PDF)

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial

Circulation (New York, N.Y.), 2007-10, Vol.116 (15), p.1647-1652

2007

Volltextzugriff (PDF)

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

Circulation (New York, N.Y.), 2005-09, Vol.112 (10), p.1451-1461

2005

Volltextzugriff (PDF)

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease

Circulation (New York, N.Y.), 2021-02, Vol.143 (5), p.470-478

2021

Volltextzugriff (PDF)

Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial

Circulation (New York, N.Y.), 2015-03, Vol.131 (12), p.1047-1053

2015

Volltextzugriff (PDF)

Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials

Circulation (New York, N.Y.), 2021-02, Vol.143 (7), p.685-695

2021

Volltextzugriff (PDF)

Extracorporeal Membrane Oxygenation in Adults With Cardiogenic Shock

Circulation (New York, N.Y.), 2015-02, Vol.131 (7), p.676-680

2015

Volltextzugriff (PDF)

Response by Bergmark et al to Letter Regarding Article, “Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial”

Circulation (New York, N.Y.), 2020-01, Vol.141 (4), p.e57-e58

2020

Volltextzugriff (PDF)

1 – 25 von 597

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(592)

Publikationsform

Artikel
(597)

Sprache

Englisch
(597)
Japanisch
(72)

Erscheinungsjahr

n.n

Thema

Cardiac & Cardiovascular Systems
(263)
Cardiovascular System & Cardiology
(263)
Life Sciences & Biomedicine
(263)
Peripheral Vascular Disease
(263)
Science & Technology
(263)
Humans
(240)
Male
(151)
Female
(147)
Middle Aged
(131)
Biological And Medical Sciences
(129)
Medical Sciences
(127)
Cardiology. Vascular System
(113)
Aged
(110)
Blood And Lymphatic Vessels
(95)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(92)
Risk Factors
(77)
Adult
(76)
Heart
(45)
Epidemiology
(43)
Pharmacology. Drug Treatments
(38)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(51)

Menü

Weitere Dienste

Einstellungen

Therapeutic Hypothermia After Cardiac Arrest

Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery

Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis–Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)

Pulling Out All the Stops: A Case of Progressive Dyspnea

Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2°P-TIMI 50

"The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial

Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus

Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control

Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease

Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial

Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials

Extracorporeal Membrane Oxygenation in Adults With Cardiogenic Shock

Response by Bergmark et al to Letter Regarding Article, “Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial”

Aktive Filter

Suchergebnisse filtern